411 related articles for article (PubMed ID: 18666600)
21. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.
Shomali W; Gotlib J
Am J Hematol; 2024 May; 99(5):946-968. PubMed ID: 38551368
[TBL] [Abstract][Full Text] [Related]
22. Hypereosinophilic syndrome presenting with bilateral ear fullness.
Jung HJ; Yu GH; Park JH
Eur Ann Otorhinolaryngol Head Neck Dis; 2019 Jun; 136(3):199-201. PubMed ID: 30683419
[TBL] [Abstract][Full Text] [Related]
23. "Idiopathic Eosinophilic Vasculitis": Another Side of Hypereosinophilic Syndrome? A Comprehensive Analysis of 117 Cases in Asthma-Free Patients.
Lefèvre G; Leurs A; Gibier JB; Copin MC; Staumont-Sallé D; Dezoteux F; Chenivesse C; Lopez B; Terriou L; Hachulla E; Launay D; Etienne N; Labalette M; DeGroote P; Pontana F; Quemeneur T; Hatron PY; Schleinitz N; Viallard JF; Hamidou M; Martin T; Morati-Hafsaoui C; Groh M; Lambert M; Kahn JE;
J Allergy Clin Immunol Pract; 2020 Apr; 8(4):1329-1340.e3. PubMed ID: 31863912
[TBL] [Abstract][Full Text] [Related]
24. Hematologic Malignancies Identified in Patients with Hypereosinophilia and Hypereosinophilic Syndromes.
Jin JJ; Butterfield JH; Weiler CR
J Allergy Clin Immunol Pract; 2015; 3(6):920-5. PubMed ID: 26342744
[TBL] [Abstract][Full Text] [Related]
25. Selective IgA deficiency mimicking Churg-Strauss syndrome and hypereosinophilic syndrome: a case report.
Takahashi N; Kondo T; Fukuta M; Takemoto A; Takami Y; Sato M; Ando T; Hashimoto N; Suzuki T; Sato J; Yamamura M; Ban N
Nagoya J Med Sci; 2013 Feb; 75(1-2):139-46. PubMed ID: 23544278
[TBL] [Abstract][Full Text] [Related]
26. Single-Organ and Multisystem Hypereosinophilic Syndrome Patients with Gastrointestinal Manifestations Share Common Characteristics.
Kuang FL; Curtin BF; Alao H; Piligian B; Berry A; Holland-Thomas N; Powers A; Quezado M; Lumbard K; Fay MP; Klion AD; Kumar S; Khoury P
J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2718-2726.e2. PubMed ID: 32344186
[TBL] [Abstract][Full Text] [Related]
27. An Approach to Hypereosinophilic Syndrome Presenting With Cutaneous Features.
Fourzali K; Yosipovitch G; Maderal A
Dermatitis; 2022 Nov-Dec 01; 33(6):387-395. PubMed ID: 36399530
[TBL] [Abstract][Full Text] [Related]
28. World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2015 Nov; 90(11):1077-89. PubMed ID: 26486351
[TBL] [Abstract][Full Text] [Related]
29. Eosinophilia with organ involvement in 3 siblings.
Ota M; Takenaka K; Takahashi M; Nagasaka K
Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(6):533-8. PubMed ID: 23291489
[TBL] [Abstract][Full Text] [Related]
30. World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2011 Aug; 86(8):677-88. PubMed ID: 21761433
[TBL] [Abstract][Full Text] [Related]
31. [Association of hyponatremia and eosinophilia: correlated idiopathic hypereosinophilic syndrome and SIADH or adrenal insufficiency with secondary eosinophilia].
Caliandro D; Bulfoni A
Clin Ter; 2003; 154(2):131-4. PubMed ID: 12856373
[TBL] [Abstract][Full Text] [Related]
32. Advances in diagnosis and treatment of eosinophilia.
Sheikh J; Weller PF
Curr Opin Hematol; 2009 Jan; 16(1):3-8. PubMed ID: 19057198
[TBL] [Abstract][Full Text] [Related]
33. [Hypereosinophilic syndromes].
Groh M; Lefèvre G; Ackermann F; Étienne N; Kahn JE
Rev Prat; 2019 Sep; 69(7):767-773. PubMed ID: 32233322
[TBL] [Abstract][Full Text] [Related]
34. The hypereosinophilic syndrome after residence in a tropical country: report of 4 cases.
Wynants H; Van Gompel A; Morales I; Vervoort T; Ponomarenko N; Surmont I; Bourgeois P; Van den Enden E; Van Marck E; Van den Ende J
Acta Clin Belg; 2000; 55(6):334-40. PubMed ID: 11484424
[TBL] [Abstract][Full Text] [Related]
35. [Diagnostic workup in front of an hypereosinophilia in 2020].
Bonnin A; Vignon G; Mottaz P; Labrousse J; Carrere F; Augereau PF; Aucher P; Lellouche F
Ann Biol Clin (Paris); 2020 Aug; 78(4):399-409. PubMed ID: 32540797
[TBL] [Abstract][Full Text] [Related]
36. World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2017 Nov; 92(11):1243-1259. PubMed ID: 29044676
[TBL] [Abstract][Full Text] [Related]
37. Hypereosinophilic syndrome and proliferative diseases.
Ionescu MA; Wang L; Janin A
Acta Dermatovenerol Croat; 2009; 17(4):323-30. PubMed ID: 20021987
[TBL] [Abstract][Full Text] [Related]
38. Evaluation and differential diagnosis of marked, persistent eosinophilia.
Mejia R; Nutman TB
Semin Hematol; 2012 Apr; 49(2):149-59. PubMed ID: 22449625
[TBL] [Abstract][Full Text] [Related]
39. Unexplained hypereosinophilia and the need for cytogenetic and molecular genetic analyses.
Smith KJ; Jacobson E; Hamza S; Skelton H
Arch Dermatol; 2004 May; 140(5):584-8. PubMed ID: 15148104
[TBL] [Abstract][Full Text] [Related]
40. [Churg-Strauss vasculitis and idiopathic hypereosinophyl syndrome: role of molecular biology in the differential diagnosis of hypereosinophyl syndrome].
Pugliese N; Bruzzone M; Della Rossa A; Baldini C; Catarsi E; Tavoni A; D'Ascanio A; Bombardieri S
Reumatismo; 2008; 60(2):120-4. PubMed ID: 18651056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
